TY - JOUR
T1 - A practical approach to differentiate the frontotemporal tauopathy subtypes
AU - Forrest, Shelley L.
AU - Halliday, Glenda M.
AU - Sizemova, Anastasia
AU - van Roijen, Marloes
AU - McGinley, Ciara V.
AU - Bright, Fiona
AU - Kapur, Milan
AU - McGeachie, Andrew B.
AU - McCann, Heather
AU - Shepherd, Claire E.
AU - Tan, Rachel H.
AU - Affleck, Andrew J.
AU - Huang, Yue
AU - Kril, Jillian J.
N1 - Funding Information:
Send correspondence to: Jillian J. Kril, PhD, Discipline of Pathology, School of Medical Sciences, Level 6 West, Charles Perkins Centre, University of Sydney, Camperdown, Sydney, NSW 2006, Australia; E-mail: jillian. [email protected] This study was funded by the National Health and Medical Research Council of Australia (program grant 1037746). Tissues were obtained from the Sydney Brain Bank, which is supported by the University of New South Wales and Neuroscience Research Australia. The authors did not receive pharmaceutical or industry support for this study.
Publisher Copyright:
© 2020 American Association of Neuropathologists, Inc. All rights reserved.
PY - 2020
Y1 - 2020
N2 - This study proposes a practical approach, using the minimum number of brain regions and stains, to consolidate previously published neuropathological criteria into one operationalized schema to differentiate subtypes of frontotemporal lobar degeneration with tau-immunopositive inclusions (FTLD-tau). This approach uses the superior frontal and precentral cortices and hippocampus stained for phosphorylated-tau, p62 and modified Bielschowsky silver, and the midbrain stained only for modified Bielschowsky silver. Accuracy of interrater reliability was determined by 10 raters in 24 FTLD-tau cases (Pick disease ¼ 4, corticobasal degeneration ¼ 9, progressive supranuclear palsy ¼ 5, globular glial tauopathy ¼ 6) including 4 with a mutation in MAPT collected with consent by Sydney Brain Bank. All brain regions and stains assessed proved informative for accurate pathological subtyping, and many neuropathological features were identified as common across the FTLD-tau subtypes. By identifying subtype-specific neuropathological features in the sections selected, 10 independent observers assigned the cases to a FTLD-tau subtype with almost perfect agreement between raters, emphasizing the requirement for the assessment of subtype-specific features for the accurate subtyping of FTLD-tau. This study consolidates current consensus diagnostic criteria for classifying FTLD-tau subtypes with an efficient, simple and accurate approach that can be implemented in future clinicopathological studies.
AB - This study proposes a practical approach, using the minimum number of brain regions and stains, to consolidate previously published neuropathological criteria into one operationalized schema to differentiate subtypes of frontotemporal lobar degeneration with tau-immunopositive inclusions (FTLD-tau). This approach uses the superior frontal and precentral cortices and hippocampus stained for phosphorylated-tau, p62 and modified Bielschowsky silver, and the midbrain stained only for modified Bielschowsky silver. Accuracy of interrater reliability was determined by 10 raters in 24 FTLD-tau cases (Pick disease ¼ 4, corticobasal degeneration ¼ 9, progressive supranuclear palsy ¼ 5, globular glial tauopathy ¼ 6) including 4 with a mutation in MAPT collected with consent by Sydney Brain Bank. All brain regions and stains assessed proved informative for accurate pathological subtyping, and many neuropathological features were identified as common across the FTLD-tau subtypes. By identifying subtype-specific neuropathological features in the sections selected, 10 independent observers assigned the cases to a FTLD-tau subtype with almost perfect agreement between raters, emphasizing the requirement for the assessment of subtype-specific features for the accurate subtyping of FTLD-tau. This study consolidates current consensus diagnostic criteria for classifying FTLD-tau subtypes with an efficient, simple and accurate approach that can be implemented in future clinicopathological studies.
KW - Frontotemporal lobar degeneration
KW - Pathological classification
KW - Tau
UR - https://www.scopus.com/pages/publications/85091266266
U2 - 10.1093/jnen/nlaa100
DO - 10.1093/jnen/nlaa100
M3 - Article
C2 - 32954432
AN - SCOPUS:85091266266
SN - 0022-3069
VL - 79
SP - 1122
EP - 1126
JO - Journal of neuropathology and experimental neurology
JF - Journal of neuropathology and experimental neurology
IS - 10
ER -